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The inheritance pattern of a number of major genetic disorders suggests the possible involvement of genes that are expressed
from one allele and silent on the other, but such genes are difficult to detect. Since DNA methylation in regulatory regions is
often a mark of gene silencing, we modified existing microarray-based assays to detect both methylated and unmethylated
DNA sequences in the same sample, a variation we term the MAUD assay. We probed a 65 Mb region of mouse Chr 7 for gene-
associated sequences that show two distinct DNA methylation patterns in the mouse CNS. Selected genes were then tested for
allele-specific expression in clonal neural stem cell lines derived from reciprocal F1 (C57BL/66JF1) hybrid mice. In addition,
using a separate approach, we directly analyzed allele-specific expression of a group of genes interspersed within clusters of
OlfR genes, since the latter are subject to allelic exclusion. Altogether, of the 500 known genes in the chromosomal region
surveyed, five show monoallelic expression, four identified by the MAUD assay (Agc1, p (pink-eyed dilution), P4ha3 and Thrsp),
and one by its proximity to OlfR genes (Trim12). Thrsp (thyroid hormone responsive SPOT14 homolog) is expressed in
hippocampus, but the human protein homolog, S14, has also been implicated in aggressive breast cancer. Monoallelic
expression of the five genes is not coordinated at a chromosome-wide level, but rather regulated at individual loci. Taken
together, our results suggest that at least 1% of previously untested genes are subject to allelic exclusion, and demonstrate a
dual approach to expedite their identification.
Citation: Wang J, Valo Z, Smith D, Singer-Sam J (2007) Monoallelic Expression of Multiple Genes in the CNS. PLoS ONE 2(12): e1293. doi:10.1371/
journal.pone.0001293
INTRODUCTION
A number of genetic disorders are characterized by a ,50%
discordance rate between identical twins [1]. These include
schizophrenia, multiple sclerosis, bipolar disorder and type 1
diabetes. While in most cases, multiple genes have been implicated
in the etiology of these diseases, allelic exclusion (i.e., random
monoallelic expression) of any one of the genes could account for
the observed pattern of inheritance in each case. An increasing
number of genes undergoing allelic exclusion are now known. The
first autosomal cases were reported for T-cell receptors [2] and
immunoglobulins [3]. More recently, allelic exclusion has been
demonstrated for additional immune response genes [4–8], as well
as chemosensory receptors, including olfactory receptors (OlfR
genes) [9] and pheromone receptors [10]. A few allelically
excluded genes with other functions have been reported as well
[11–13]. Epigenetic factors contributing to monoallelic expression
include DNA methylation differences at regulatory regions as well
as DNA replication asynchrony; these epigenetic changes may
occur early in development, providing markers for subsequent
allele-specific expression (reviewed in [14] and [15]).
Because random allelic exclusion results in two simultaneous
patterns of expression in a mixture of cells, it has been difficult to
detect in tissues. Several groups have used allele-specific single-cell
analysis [16,17], but the method is not sensitive enough for the
detection of genes expressed at low or moderate levels. An
alternative approach, increasingly in use, involves detection of
methylated CpG islands, which are frequently correlated with
imprinting and monoallelic expression; the assays usually depend
upon restriction enzyme analysis to identify differences in DNA
methylation between different samples [18,19]. The advent of
high-density microarrays, including tiling arrays that contain
probes for all non-repetitive sequences along a given chromosome,
has led to the development of assays for detection of methylated
DNA by microarray analysis [20–22]. We have modified that
approach to detect genes that have a dual DNA methylation
pattern within the same tissue. To provide proof-of-principle we
chose the mouse CNS as a model system, probing the portion of
mouse Chr 7 that includes the imprinted Prader-Willi/Angelman
Syndrome (PWS/AS) locus [23]: The differentially methylated
Snrpn gene lies within this locus [24], providing a positive control.
Our analysis confirmed that the method can be used to identify
monoallelic expression and, in addition, identifies four genes
expressed monoallelically in the CNS.
To test for monoallelic expression we identified SNPs in
candidate genes, and then analyzed allele-specific expression in
clonal neural stem cell (NSC) lines we derived from F1 hybrid
mice. In addition, in a separate approach, we directly analyzed
allele-specific expression of genes that were selected on the basis of
proximity to OlfR gene clusters. The rationale for selection of OlfR
genes was that they are the major gene family thus far known to
undergo random allelic exclusion in CNS tissue [9,25,26]. In
addition, their occurrence in clusters was similar to that of most
other known monoallelically expressed genes, particularly im-
printed genes, that have been the most studied (http://www.mgu.
har.mrc.ac.uk/research/imprinting). Using this approach, we
identified an additional gene showing monoallelic expression.
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The MAUD Assay
Figure 1 shows a schematic diagram of the microarray-based assay
that we used, modified specifically for the simultaneous detection
of both methylated and unmethylated DNA sequences. Genomic
DNA was cleaved with the enzyme Csp6I (G*TAC) to generate
fragments ,0.5 to 1 kb in length. Universal linkers were then
added, and each sample was divided into three aliquots. The first
(‘‘A’’) aliquot was digested with McrBC, which cleaves methylated
DNA sequences, leaving unmethylated DNA intact. The second
(‘‘B’’) aliquot was treated with a mix of methyl-sensitive restriction
enzymes (‘‘RE mix’’, composed of HpaII, AciI, and HpyCH4IV)
that cleave DNA only at unmethylated sites. A third (‘‘C’’) aliquot
was treated with both McrBC and the RE mix, providing a
negative control. Following amplification by LM-PCR, and
fluorescent (Cy3 or Cy5) labeling, two microarray-based hybrid-
izations were performed: the first compared McrBC-treated
sample A with the control sample C, and the second compared
RE-mix-treated sample B with the same control. Hits are defined
as sequences that give a strong positive signal in both
hybridizations.
We analyzed the 65 Mb portion of mouse Chr 7 shown in
Figure 2, utilizing tiling arrays containing probes for all non-
repetitive DNA at 100 bp intervals. While we examined only
sequences in the vicinity of genes, we selected tiling arrays rather
than promoter or GC-island arrays to include sequences that
might be missed by a narrow definition of GC-rich regions or
because of incomplete annotation of transcription start sites. For
each gene, we scanned up to 16 kb of DNA surrounding the
transcription start site(s) to include 8 kb of the 59 region as well as
the first exon and first intron.
The region we selected includes the imprinted PWS/AS locus as
well as several clusters of olfactory receptor (OlfR) genes, as shown
in Figure 2. While subsequent tests of allele-specificity necessarily
relied on cells derived from F1 hybrids, for microarray analysis we
used an inbred strain (C57BL/6), avoiding potential artifacts due
to use of hybrid strains. We assayed DNA from mouse brain
Figure 1. Outline of the MAUD assay. Open circles, unmethylated DNA, closed circles, methylated DNA. RE mix; AciI, HpaII and HpyCH4IV. The boxed
sequences remain intact following the indicated enzymatic treatment, and are subsequently amplified by LMPCR.
doi:10.1371/journal.pone.0001293.g001
Figure 2. Region of mouse Chr 7 assayed and summary of results. Upper line. The location in Mb of the PWS/AS locus is shown by the turquoise bar,
and that of the OlfR clusters by the green bars. Lower line. The location of genes assayed for allele-specific expression is shown. Monoallelically
expressed genes are indicated by red triangles; bi-allelically expressed genes by vertical lines (see text).
doi:10.1371/journal.pone.0001293.g002
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mixture of various cell types, we reasoned that a high proportion of
brain-derived total RNA is transcribed from neurons and
astrocytes, so that a dual DNA methylation pattern in either or
both of these cell types might be detectable above background.
Figures 3A and 3B show the hybridization profiles for the
promoters of Snrpn and H47. While the Snprn gene is known to be
imprinted and differentially methylated [24], H47 is bi-allelically
expressed (our unpublished data). For both genes there is a clear
peak in the lower track, representing unmethylated DNA;
however, only the Snrpn promoter shows a peak in the upper
track, representing methylated DNA. Control experiments
confirmed that the active and silent alleles of the Snrpn gene were
in the McrBC- and RE mix- treated samples, respectively, and also
that the H47 promoter is unmethylated (Figure S1).
The patterns of signal intensity of the peaks in Figures 3A and 3B
are compatible with the method we used to prepare the DNA
samples, i.e., signal intensity was generally highest in the middle of
Csp6I restriction fragments, with double peaks seen if a particular
GC-rich region spanned more than one fragment. Often the central
portion of a GC-rich region, containing a dense concentration of
methyl-sensitive restriction sites, showed poor signal intensity, but
was surrounded by sizable peak shoulders (see, for example, Figure
S2, Agc1 promoter region). Because these peaks may escape
conventional peak-finding algorithms, we used visual inspection to
select genes for further analysis by allele-specific RT-PCR. Of 50
genes we selected, 10 genes were not assayable for technical reasons
(e.g., no SNPs or no RT-PCR product in brain). Of the remaining
40 genes, 36 showed bi-allelic expression, and four showed
monoallelic expression (see below and Table S2).
As a first step in development of a computational tool for peak
analysis, we used the newly found monoallelically expressed genes
and Snrpn as a ‘‘learning tool’’ to optimize criteria for peak
selection (Text S1). A Venn diagram (Figure 3B) summarizes the
result we obtained by using the automated criteria to analyze 3
separate mouse samples. The diagram shows that the method is
reproducible, and that it yields a manageable number of candidate
genes that show a dual DNA methylation pattern in all three mice.
Verification of Monoallelic Expression
To test which of the identified genes showed monoallelic
expression, we analyzed the RNA of six hybrid clonal lines of
NSCs. Three of the clonal lines were derived from pooled CNS
tissue of F1 (B6R6JF1=) female mice, and the other three lines
were similarly derived from F1 progeny of the reciprocal cross.
Figure 4 shows the different patterns of expression for the four
genes found to be monoallelically expressed in at least three of the
clonal lines: Agc1, coding for aggrecan (chondroitin sulphate
proteoglycan), a necessary component of the matrix of cartilage-
containing tissues; Thrsp, coding for a thyroid hormone- responsive
protein that is expressed in the hippocampus (Allen Brain Atlas,
www.brain-map.org), and that also catalyzes the synthesis of long
chain fatty acids in breast tissue in human [27]; p, pink-eyed
dilution protein (human gene OCA2), which is linked to albinism
[28]; and P4ha3, coding for the alpha subunit of a protein that
catalyzes the hydroxylation of proline in collagen. For two of the
genes, p and P4ha3, all of the cell lines tested show monoallelic
expression. The other two genes, Agc1 and Thrsp, are expressed
from the B6 allele in some clonal lines and bi-allelically in others.
Complete results for each gene are shown in Figure S3, together
with standard curves demonstrating the quantitative nature and
resolution of the sequencing assay for each SNP used. For each of
the genes, differential DNA methylation of a region included
within the observed peaks was confirmed by bisulfite sequencing
(Figure S4).
Direct Assay of Genes near OlfR Clusters
We analyzed allele-specific expression of 10 genes that are in the
vicinity of OlfR gene clusters on Chr 7 (see Figure 2), that contain
Figure 3. MAUD assay controls and reproducibility. Hybridization profiles are shown for A. Snrpn and B. H47. For each gene, the x-axis shows our
data aligned with the nucleotide position of genes and restriction sites along mouse Chr 7 (UCSC genome browser). The y-axis represents the log2
ratio for RE treated-DNA vs. control (upper track, blue bars) and McrBC- treated DNA vs. control (lower track, purple bars). Each bar represents the
value for an individual probe. The numbers above the peaks indicate the peak height for mouse 1; similar log2 ratios were found for all three mice.
Below each set of tracks, the vertical lines above show the location of Csp6I sites, and the lines below show the location of DNA methylation-sensitive
HpaII AciI and HpyCH4IV sites. Horizontal arrows indicate the start site and orientation of transcription for each gene. The small turquoise boxes
highlight the sequences analyzed for differential DNA methylation in Figure S4. C. Evidence for reproducibility. The Venn diagram shows positive hits
(genes with clear peaks in both upper and lower tracks) in the three mice assayed. Criteria for peak selection are described in Text S1.
doi:10.1371/journal.pone.0001293.g003
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Nine of these showed bi-allelic expression (Table S2), and one,
Trim12, tripartite motif protein (no human homolog) showed
monoallelic expression (Figure 5). In addition to its proximity to
OlfR clusters, a BLAT search (http://genome.ucsc.edu) revealed
that the 1500-bp Trim12 gene is surrounded by five genomic
sequences that are nearly identical to it (80% to 96% identity over
at least 30% of the gene within a 270 kb region surrounding it).
Summary of Results
Figure 2 summarizes our results, showing the location of the five
monoallelically expresssed genes (red triangles) scattered among
the 45 genes that are bi-allelically expressed (vertical lines). We see
no evidence for enrichment of monoallelic expression in a
particular chromosomal region. Figure 6 shows the allele-specific
expression pattern of the five genes on each of the two copies of
Chr 7 in each clonal NSC line. Red lines indicate the expressed
allele(s) in each case. It is apparent that there is no chromosome-
wide coordination of allele-specific expression. For P4ha3, p and
Agc1, the clonal lines derived from the same cell line (i.e., NSC2 or
Figure 4. Monoallelic expression of Agc1, p, P4ha3 and Thrsp in NSC clones. The panels show sequencing results following RT-PCR of RNA from
representative F1 hybrid NSC clonal lines. Results for all six lines as well as standard curves showing the resolution of the sequencing assay are shown
in Figure S3.
doi:10.1371/journal.pone.0001293.g004
Figure 5. Monoallelic expression of Trim12. A restriction fragment
length polymorphism permitted the use of agarose gel electrophoresis
rather than sequencing to analyze allele-specific expression. A. RT-PCR
products from parental strains B6 and JF1 and the six NSC clonal lines
are shown. B. PCR of genomic DNA from two NSC clonal lines 2A1 and
3A1, the NSC parental strains NSC2 and NSC3, and brain DNA from
strains F1 (B6R6JF1=)( F 1a), and the reciprocal cross (F1b) are shown.
doi:10.1371/journal.pone.0001293.g005
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the genes, Agc1 and p, the parent NSC2 or NSC3 cell line is
already skewed (Figure S3), suggesting that the original cell lines
we obtained were oligoclonal to begin with.
For four of the genes, the results summarized in Figure 6 do not
suggest any parent-of-origin effects. The results shown for p might
suggest the possibility of imprinting, since the maternal allele is
expressed in each of the 5 clonal lines assayed; however, the bi-
allelic pattern seen in F1 (B66JF1) brain RNA for both reciprocal
crosses (Figure S3) suggests that this is not the case for most CNS
cells. The possibility of imprinting in neural stem cells cannot be
ruled out, however.
DISCUSSION
We have detected five genes that are monoallelically expressed in
the CNS by analysis of DNA methylation patterns or proximity to
OlfR genes, followed by the direct assay of F1 hybrid clonal cell
lines. The approach should prove useful for identification of
monoallelic expression in other tissues and elsewhere in the
genome, the major limitation being the difficulty of obtaining
clonal cell lines for some cell types.
The assay we describe for detection of methylated and
unmethylated DNA has a number of advantages in addition to
its potential for high-throughput analysis: Inbred strains may be
assayed, avoiding artifacts due to strain differences, and the use of
tiling arrays allows latitude in defining sequences of interest.
However the assay also has limitations: 1) Not all allelic exclusion
is associated with differential DNA methylation. An example of
this is the imprinted Ndn gene within the PWS/AS locus, which
shows heterogeneity of methylation patterns on both alleles in the
brain ([29] and our unpublished data). 2) The assay depends upon
having completely methylated or unmethylated DNA at the
relevant restriction sites within a given Csp6I fragment: If a
fragment shows partial methylation on either the silent or active
allele, the signal for that allele will probably escape detection. For
example, partial methylation at some methyl-sensitive restriction
sites is the probable cause of our failure to observe a reproducible
signal for two additional imprinted genes within the PWS/AS
locus, Peg12 and Mkrn3 ([30] and our unpublished data). 3) Very
highly GC-rich regions may show attenuated or no hybridization
signal, possibly due to the difficulty of amplification. The latter two
limitations are somewhat ameliorated by use of a broad window
(transcription start point68 kb); a gene is included among ‘‘hits’’ if
any one of the Csp6I fragments within the window exceeds the
signal threshold.
Although rigorous statistical analysis will not be useful until
more data sets are obtained by use of our ‘‘supervised learning’’
approach, it seems very likely that we have enriched for genes
undergoing allelic exclusion by use of our DNA methylation-based
assay. Empirically we found that the assay reduced the list of
potentially ‘‘interesting’’ genes to a manageable number (50 to 60
genes showing dual DNA methylation patterns), and that of these
genes 10% were monoallelic (4 of the 40 genes for which we found
usable SNPs).
We estimate that a minimum of ,1% of previously untested
genes (5 of 500 genes surveyed) undergo allelic exclusion in
addition to those already known. This estimate is consistent with
the findings of Gimelbrant and Chess [31], who used an approach
based on asynchronous replication. For two of the genes, we found
monoallelic expression in all six clonal cell lines, while for the three
others, we found a mixed pattern, with some lines showing bi-
allelic expression. This is not likely to be a tissue culture artifact.
When brain tissue was assayed for DNA methylation, the genes
showing the most clear-cut dual methylation profiles in the
MAUD assay were those showing monoallelic expression in all the
clonal lines (Figure S2). In addition our control experiments
(unpublished) showed that the cell lines all retained silencing of X-
linked genes, and a mixed pattern for genes that are mono- or bi-
allelically expressed in the CNS depending upon cell type or stage
of development [32].
For the five genes we report here, the pattern of allele-specific
expression appears to show no chromosome-wide coordination.
This was expected, based upon previously published work showing
gene-to-gene variability in expression patterns, even within
monoallelically expressed gene clusters. For example, cytokines
and the NK cell receptors are regulated in a probabilistic manner,
with cells in an activated clonal population capable of expressing
either or both alleles; [4,6,7]. It has been suggested that this
stochastic process is part of development of the immune response
repertoire. IL-4, Il-5 and IL-13 lie within 140 kb of each other,
and are coordinately regulated [8]; however, IL-3, which lies
within 450 kb of these genes, shows allele-specific expression that
is regulated independently of the neighboring cytokines.
Even when there is co-ordinated control within an imprinted
domain, the regulation mechanism may involve oppositely
imprinted genes within the domain. For example at the PWS/
AS locus the tightly regulated paternally expressed Snrpn gene is
within 1 Mb of the Ube3a gene, which is oppositely imprinted in
some cells of the CNS and bi-allelically expressed in others [33].
Singh et al. [34] reported evidence for chromosome-wide co-
ordination of asynchronous replication of OlfR and immune
response genes, but their results are not necessarily at variance
with locus-specific control. It may be that allele-specific expression
of some subclasses of genes is regulated at a chromosomal level, or
Figure 6. Monoallelic expression patterns are locus-specific. The
region of Chr 7 from 48 Mb to 115 Mb is shown schematically (not
drawn to scale). The clonal lines were derived from either NSC2 cells
(JF1R6B6=) or NSC3 cells (B6R6JF1=) as shown. *, not determined.
doi:10.1371/journal.pone.0001293.g006
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preclude a random pattern of allele-specific expression.
Trim12, the monoallelically expressed gene that we selected by
proximity to OlfR genes, is also surrounded by recently duplicated
sequences and LINE elements, which are generally abundant at
OlfR clusters [35]. Previous work has suggested a link between
some monoallelic expression (and asynchronous replication) and
gene duplication/repetitive elements [31,36]. There has been
recent interest in the origins of this association, including
speculation that tissue-specific silencing of duplicated genes might
be evolutionarily advantageous directly or indirectly [31,37,38].
While more work is needed in this area, it will be worthwhile to
continue to use the potential link between allelic exclusion and
sequence duplication in the search for new candidate genes.
Relevance of Monoallelic Expression to Human
Disorders
The search for genes undergoing allelic exclusion, in conjunction
with mapping of disease susceptibility loci, may help identify
candidate genes for genetic disorders that display discordance
among identical twins. Such genes are also of interest in that they
are more vulnerable to genetic and spontaneous mutation because
allelic exclusion results in functional hemizygosity. Finally, an
understanding of the silencing mechanism for genes undergoing
allelic exclusion should prove valuable in designing eventual
therapies in cases where such genes are implicated in specific
disorders.
The potential importance of understanding allele-specific gene
silencing is underscored for three of the genes we have identified,
Agc1, Thrsp and P4ha3. Proof of monoallelic expression for these
genes in human tissue would constitute a separate study, but it is
worth noting that in mice, mutation of Agc1 leads to a lethal
phenotype at birth, and that there is a possible link to the human
genetic disorder achondroplasia [39]. In the case of Thrsp and
P4ha3, studies on humans have shown that over-expression of the
genes may be deleterious, associated with a poor prognosis for
breast cancer and with atherosclerosis, respectively [27,40,41]. For
genes such as these, knowledge of the endogenous silencing
mechanism might be a first step in reversing over-expression of a
mutant allele or re-activating a silent one.
MATERIALS AND METHODS
Mouse Strains and Neural Stem Cell (NSC) lines
Four-to-eight week-old C57BL6 (B6), Japanese Fancy Mouse 1
(JF1) and F1 hybrid female offspring of B66JF1 mice were used.
Isolation of NSC2 and NSC3 lines and the clonal cell lines derived
from them is described in Text S2. Clonal cell lines 2A1, 2A4 and
2A5 were isolated from cell line NSC2, derived from F1
(JF1R6B6=) mice; clonal lines 3A1, 4A5 and 4B3 were from cell
line NSC3, derived from F1 (B6R6JF1=) mice.
All clonal lines tested retained X-chromosome inactivation as
measured by allele-specific expression of Rps4x and Pgk1. The
chromosome number of several clonal lines tested was near-
euploid, but, because of some variation in karyotype with passage
number, for each gene showing monoallelic expression we verified
the presence of both alleles by PCR (Figure S3).
DNA and RNA Isolation
Genomic DNA was extracted from minced brain by treatment
with proteinase K, followed by phenol-chloroform extraction and
ethanol precipitation. DNA from cultured NSC lines was extracted
with the WizardH Genomic DNA Purification Kit (Promega,
Madison, WI). Total RNA from brain or NSC lines was isolated
by use of TRIZOL (Invitrogen, Carlsbad, CA).
The MAUD Assay
DNA (4 mg) was digested with 20 U of Csp6I for 4 hr at 37uC
(Fermentas, Hanover, MD). The resulting restriction fragments
were ligated to adaptor set TA-1b as previously described [22],
except that incubations were carried out at 16uC for 16 hr. DNA
was then divided into aliquots, and digested in one of three ways
(restriction enzymes and buffers were all from New England
Biolabs (Ipswich, MA)): A. DNA was treated with McrBC; B, DNA
was digested first with HpaII and HpyCH4IV in buffer 1, then
with AciI in buffer 3; the two steps each consisted of two rounds of
incubation, 1.5 hr each, with 3–5 U enzyme per mg DNA added
at each round: C, control DNA was treated with McrBC and the
three additional restriction enzymes. All samples were purified by
use of a Qiaquick PCR purification kit (Qiagen, Valencia CA)
following each enzymatic step.
Amplification by LM-PCR was carried out as previously
described [22] with modification. Each ligated and digested
DNA sample (600 ng) was amplified in 6 Eppendorf tubes, each
containing 100 ng of DNA, 16 ThermoPol Reaction Buffer,
2.0 mM MgSO4, 200 mM dNTPs, 400 pm of primer TA-1b, and
3 U Vent
exo2 (New England Biolabs), in a final volume of 100 ml.
The amplified DNA was purified by use of the QIAquick PCR
purification kit. Real time PCR was performed for each of the
amplified DNA samples to confirm at least an 8-fold enrichment
for known differentially methylated sequences in samples A and B
compared with sample C (data not shown).
Microarray Analysis and Data Processing
Amplified DNA samples were shipped to Nimblegen Systems Inc.
(Madison, WI) for hybridization to MM8 set16 tiling arrays
(mouse Chr 7 48 Mb to 115 Mb). For each mouse, results of the
two hybridizations (A vs. C, and B vs. C, see Figure 1) were
examined visually by use of SignalMap (Nimblegen) or the UCSC
Genome Bioinformatics browser (http://genome.ucsc.edu)
[42,43]. The distance from each peak to the nearest gene on
mouse Chr 7 was determined after downloading the pertinent files
from the UCSC website. Peaks of interest were defined as either
less than 8 kb upstream of a transcription start site or within the
first exon or first intron of a given gene. ‘‘Hits’’ were selected for
further analysis after exclusion of OlfR genes and genes not
expressed in the brain as determined by use of the Unigene gene
viewer (http://www.ncbi.nlm.nih.gov), and the Allen Brain Atlas
(http://www.brain-map.org). Details of the automated peak
selection protocol we used subsequently are in Text S1.
Assay for Monoallelic Expression
Primers, SNPs and specific PCR conditions are listed in Table S1.
Primers were designed by use of primer3 (http://frodo.wi.mit.
edu). SNPs were identified by RT-PCR of B6 and JF1 brain RNA
followed by automated DNA sequencing (City of Hope DNA
sequencing Core). RT was carried out on total RNA (1.0 mg) by
use of ThermoScript
TM kits (Invitrogen) with oligo(dT) primers.
One ml of each 20-ml reaction mix was then used for amplification
by PCR. Each reaction mix contained, in a final volume of 50 ml,
PCR buffer II, 200 mM dNTPs, MgCl2, 100 pm of each primer,
and 0.8 U Amplitaq DNA polymerase (Applied Biosystems, Foster
City CA). After an initial denaturation (5 min 95uC), amplification
was carried out for up to 35 cycles of 94uC for 45 s, annealing
temperature for 45 s, 72uC for 1 min, followed by a final
elongation step at 72uC for 5 min. RT-PCR products were gel-
CNS Monoallelic Expression
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Extraction Kit (Qiagen) prior to sequencing.
SUPPORTING INFORMATION
Figure S1 DNA methylation of control genes. A. Sequence
analysis of the amplified Snrpn promoter shows allele-specific
DNA methylation. Two left panels: Identification of a SNP
between strains B6 and JF1. Middle panel: Both alleles are present
in F1 progeny of the cross (JF1MAT6B6PAT). Two right panels:
The unmethylated paternal or methylated maternal allele remains
intact following treatment with McrBC or the RE mix (HpaII-
AciI-HpyCH4IV), respectively. The primers used were previously
described to identify the same polymorphism 104 bp upstream of
the major transcription start site for Snrpn in Mus musculus
castaneus-Ei [1]. B. Bisulfite analysis of CpG sites within the H47
promoter. DNA from mouse forebrains was treated with McrBC
or the RE mix, but only McrBC-treated DNA yielded a PCR
product; amplified DNA samples were sequenced directly
following bisulfite treatment without sub-cloning. Each line shows
results for one mouse (n=3). The CpG sites within the amplicon
are numbered. Restriction sites for McrBC, AciI, HpaII and
HpyCH4IV are indicated by M, A, H and Y, respectively. The
legend to Figure S4 contains details of bisulfite sequencing.
Primers and chromosomal co-ordinates for the region analyzed
are listed in Table S1. Reference 1. Xin Z, Tachibana M,
Guggiari M, Heard E, Shinkai Y, et al. (2003) Role of histone
methyltransferase G9a in CpG methylation of the Prader-Willi
syndrome imprinting center. J Biol Chem 278: 14996–15000.
Found at: doi:10.1371/journal.pone.0001293.s001 (0.37 MB
PDF)
Figure S2 Detection of dual DNA methylation patterns by the
MAUD assay. Results are shown for genes subsequently found to
be monoallelically expressed. A. Agc1. B. p (pink-eye dilution). C.
P4ha3. D. Thrsp. The x-axis shows the nucleotide position along
mouse Chr 7 (numbered at the top). The y-axis indicates the log2
ratio for RE mix-treated DNA vs. control (top track) and McrBC-
treated DNA vs. control (bottom track). Maxium peak height
(log2) ratios are indicated for peaks that are coincident in both
tracks. Results are shown for mouse 1; similar ratios were found
for all three mice. Below the two tracks, the blue vertical lines (top)
show the location of Csp6I sites, and the black lines (bottom) show
the location of DNA methylation-sensitive HpaII AciI and
HpyCH4IV sites. Short horizontal arrows indicate the start site
and orientation of transcription for each gene; just above each
arrow, the positions of exons (bars) and introns (small arrows) are
shown. The turquoise boxes highlight the regions analyzed by
bisulfite sequencing (Figure S4). The figures were obtained by
alignment of our custom tracks with annotation showing the
location of the genes and restriction enzyme sites indicated (UCSC
Genome Browser).
Found at: doi:10.1371/journal.pone.0001293.s002 (0.04 MB
PDF)
Figure S3 Monoallelic expression of Agc1, p, P4ha3 and Thrsp.
Allele-specific expression for each gene was measured by
automated sequencing of RT-PCR products containing SNPs.
For A-D, Top row, brain tissue from B6 and JF1 mice and F1
hybrid progeny. Middle and bottom rows, NSC2- and NSC3-
derived clonal lines, respectively. The parental cell lines NSC2 and
NSC3 are shown at the left. Results of PCR of genomic DNA from
representative clonal lines are shown as indicated, verifying the
presence of both alleles. E. Quantitation and resolution of the
assay. For each gene RT-PCR products of strains B6 and JF1 were
mixed in the proportions shown prior to automated sequencing (%
input). The relative intensity (peak height) of the signal for each
base at SNP sites was measured to determine the % signal. For
each RNA sample analyzed, if more than one base was detected at
a SNP, expression was considered to be monoallelic if the
predominant base comprised at least 95% of the signal. At least
three technical replicates were performed for each cell line, giving
the same result.
Found at: doi:10.1371/journal.pone.0001293.s003 (1.31 MB
PDF)
Figure S4 Bisulfite analysis of CpG sites for Agc1, p, P4ha3 and
Thrsp. Upper panels, McrBC-treated DNA; lower panels, RE
mix-treated DNA. CpG sites included within each amplicon are
numbered. Bisulfite sequencing of DNA of mouse 1 was carried
out by use of the Methylation-Gold Kit (ZYMO, Orange, CA).
PCR reaction mixes contained in a 20 ml volume, 50 ng of
bisulfite-modified DNA, 16 PCR buffer, 2.0 mM MgCl2,
200 mM dNTPs, 40 pm of each primer, and HotStart Taq
DNA polymerase, 0.5 U (Qiagen). PCR conditions were: 95uC for
15 min, followed by 35 cycles of 94uC for 45 s, annealing
temperature for 45 s, and 72uC for 40 s, followed by a final
incubation at 72uC for 5 min. PCR products were purified by use
of the QIAquick Gel Extraction Kit (Qiagen), and then subcloned
into the vector pCR2.1 (Invitrogen) prior to sequencing.
Restriction sites for McrBC, AciI, HpaII and HpyCH4IV are
indicated by M, A, H and Y, respectively. Primer sequences and
annealing temperatures are listed in Table S1. The chromosomal
co-ordinates of the regions analyzed are listed in Table S1, and
visually shown in Figure S2. Note that for Thrsp CpG site 2
appears to be methylated although it is resistant to McrBC
cleavage, consistent with occasional bias that we and others
observe following subcloning of bisulfite-treated DNA.
Found at: doi:10.1371/journal.pone.0001293.s004 (0.05 MB
PDF)
Table S1 List of primers. The list includes primers for PCR,
RT-PCR and bisulfite sequencing as well as PCR conditions.
Found at: doi:10.1371/journal.pone.0001293.s005 (0.03 MB
PDF)
Table S2 Bi-allelic expression of genes on mouse Chr 7. The list
includes 36 genes analyzed by RT-PCR of clonal hybrid neural
stem cell lines
Found at: doi:10.1371/journal.pone.0001293.s006 (0.09 MB
PDF)
Text S1 Automated peak selection. The computational method
used to analyze the peaks obtained by microarray hybridization is
described.
Found at: doi:10.1371/journal.pone.0001293.s007 (0.02 MB
DOC)
Text S2 Isolation of NSCs and clonal cell lines
Found at: doi:10.1371/journal.pone.0001293.s008 (0.04 MB
DOC)
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